Transcription factor AP-1 in esophageal squamous cell carcinoma: Alterations in activity and expression during human papillomavirus infection

BMC Cancer

Volumn 9, Issue , 2009, Pages 329-

  Hussain, Showket ^a   Bharti, Alok C ^a   Salam, Irfana ^b   Bhat, Mohammad A ^b   Mir, Mohammad M ^b   Hedau, Suresh ^a   Siddiqi, Mushtaq A ^b   Basir, Seemi F ^c   Das, Bhudev C ^a,d  

^a Institute of Cytology and Preventive Oncology (ICMR)   (India)

^b SHER I KASHMIR INSTITUTE OF MEDICAL SCIENCES   (India)

^c JAMIA MILLIA ISLAMIA CENTRAL UNIVERSITY   (India)

^d UNIVERSITY OF DELHI   (India)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; PROTEIN C FOS; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR FRA 1; TRANSCRIPTION FACTOR JUNB;

ADULT; ARTICLE; CONTROLLED STUDY; DNA BINDING; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS SURGERY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN TISSUE; IMMUNOBLOTTING; INDIA; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; VIRUS CARCINOGENESIS; VIRUS IDENTIFICATION; VIRUS INFECTION; WART VIRUS;

ADULT; AGED; AGED, 80 AND OVER; ALPHAPAPILLOMAVIRUS; CARCINOMA, SQUAMOUS CELL; ESOPHAGEAL NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INDIA; MALE; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; PROTEIN BINDING; TRANSCRIPTION FACTOR AP-1;

EID: 70449413106     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-9-329     Document Type: Article

References (41)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005, 55:74-108.
2. Siddiqi M, Preussmann R. Esophageal cancer in Kashmir--an assessment. J Cancer Res Clin Oncol 1989, 115:111-117.
3. Kumar R, Mende P, Wacker CD, Spiegelhalder B, Preussmann R, Siddiqi M. Caffeine-derived N-nitroso compounds--I: Nitrosatable precursors from caffeine and their potential relevance in the etiology of oesophageal and gastric cancers in Kashmir, India. Carcinogenesis 1992, 13:2179-2182.
4. Khuroo MS, Zargar SA, Mahajan R, Banday MA. High incidence of oesophageal and gastric cancer in Kashmir in a population with special personal and dietary habits. Gut 1992, 33:11-15. 1373857, 1740265.
5. Murtaza I, Mushtaq D, Margoob MA, Dutt A, Wani NA, Ahmad I, Bhat ML. A study on p53 gene alterations in esophageal squamous cell carcinoma and their correlation to common dietary risk factors among population of the Kashmir valley. World J Gastroenterol 2006, 12:4033-4037.
6. Lam KY, Tsao SW, Zhang D, Law S, He D, Ma L, Wong J. Prevalence and predictive value of p53 mutation in patients with oesophageal squamous cell carcinomas: a prospective clinico-pathological study and survival analysis of 70 patients. Int J Cancer 1997, 74:212-219.
7. Parkin DM, Bray F. Chapter 2: The burden of HPV-related cancers. Vaccine 2006, 24(Suppl 3):11-25.
8. Syrjanen KJ. HPV infections and oesophageal cancer. J Clin Pathol 2002, 55:721-728. 1769774, 12354793.
9. Katiyar S, Hedau S, Jain N, Kar P, Khuroo MS, Mohanta J, Kumar S, Gopalkrishna V, Kumar N, Das BC. p53 gene mutation and human papillomavirus (HPV) infection in esophageal carcinoma from three different endemic geographic regions of India. Cancer Lett 2005, 218:69-79.
10. Offord EA, Beard P. A member of the activator protein 1 family found in keratinocytes but not in fibroblasts required for transcription from a human papillomavirus type 18 promoter. J Virol 1990, 64:4792-4798. 247967, 2168967.
11. Karamouzis MV, Konstantinopoulos PA, Papavassiliou AG. The activator protein-1 transcription factor in respiratory epithelium carcinogenesis. Mol Cancer Res 2007, 5:109-120.
12. Thierry F, Spyrou G, Yaniv M, Howley P. Two AP1 sites binding JunB are essential for human papillomavirus type 18 transcription in keratinocytes. J Virol 1992, 66:3740-3748. 241159, 1316480.
13. de Wilde J, De-Castro Arce J, Snijders PJ, Meijer CJ, Rosl F, Steenbergen RD. Alterations in AP-1 and AP-1 regulatory genes during HPV-induced carcinogenesis. Cell Oncol 2008, 30:77-87.
14. Mishra A, Bharti AC, Varghese P, Saluja D, Das BC. Differential expression and activation of NF-kappaB family proteins during oral carcinogenesis: Role of high risk human papillomavirus infection. Int J Cancer 2006, 119:2840-2850.
15. Coia LR, Myerson RJ, Tepper JE. Late effects of radiation therapy on the gastrointestinal tract. Int J Radiat Oncol Biol Phys 1995, 31:1213-1236.
16. Esophagus. Manual for the Staging of Cancer 1992, 57-59. Cancer AJCo. Philadelphia: JB Lippincott, 4.
17. Das BC, Sharma JK, Gopalakrishna V, Luthra UK. Analysis by polymerase chain reaction of the physical state of human papillomavirus type 16 DNA in cervical preneoplastic and neoplastic lesions. J Gen Virol 1992, 73(Pt 9):2327-2336.
18. Kailash U, Soundararajan CC, Lakshmy R, Arora R, Vivekanandhan S, Das BC. Telomerase activity as an adjunct to high-risk human papillomavirus types 16 and 18 and cytology screening in cervical cancer. Br J Cancer 2006, 95:1250-1257. 2360573, 17060942.
19. Dignam JD. Preparation of extracts from higher eukaryotes. Methods Enzymol 1990, 182:194-203.
20. Rosl F, Das BC, Lengert M, Geletneky K, zur Hausen H. Antioxidant-induced changes of the AP-1 transcription complex are paralleled by a selective suppression of human papillomavirus transcription. J Virol 1997, 71:362-370. 191059, 8985358.
21. Prusty BK, Das BC. Constitutive activation of transcription factor AP-1 in cervical cancer and suppression of human papillomavirus (HPV) transcription and AP-1 activity in HeLa cells by curcumin. Int J Cancer 2005, 113:951-960.
22. Chang L, Karin M. Mammalian MAP kinase signalling cascades. Nature 2001, 410:37-40.
23. Ransone LJ, Verma IM. Nuclear proto-oncogenes fos and jun. Annu Rev Cell Biol 1990, 6:539-557.
24. Angel P, Karin M. The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation. Biochim Biophys Acta 1991, 1072:129-157.
25. Karin M, Liu Z, Zandi E. AP-1 function and regulation. Curr Opin Cell Biol 1997, 9:240-246.
26. Shaulian E, Karin M. AP-1 as a regulator of cell life and death. Nat Cell Biol 2002, 4:E131-136.
27. Abdel-Latif MM, Windle H, Terres A, Eidhin DN, Kelleher D, Reynolds JV. Helicobacter pylori extract induces nuclear factor-kappa B, activator protein-1, and cyclooxygenase-2 in esophageal epithelial cells. J Gastrointest Surg 2006, 10:551-562.
28. Dhar GM, Shah GN, Naheed B, Hafiza. Epidemiological trend in the distribution of cancer in Kashmir Valley. J Epidemiol Community Health 1993, 47:290-292. 1059795, 8228764.
29. Passegue E, Jochum W, Behrens A, Ricci R, Wagner EF. JunB can substitute for Jun in mouse development and cell proliferation. Nat Genet 2002, 30:158-166.
30. Li T, Dai W, Lu L. Ultraviolet-induced junD activation and apoptosis in myeloblastic leukemia ML-1 cells. J Biol Chem 2002, 277:32668-32676.
31. Robinson CM, Prime SS, Huntley S, Stone AM, Davies M, Eveson JW, Paterson IC. Overexpression of JunB in undifferentiated malignant rat oral keratinocytes enhances the malignant phenotype in vitro without altering cellular differentiation. Int J Cancer 2001, 91:625-630.
32. Wu MY, Zhuang CX, Yang HX, Liang YR. Expression of Egr-1, c-fos and cyclin D1 in esophageal cancer and its precursors: An immunohistochemical and in situ hybridization study. World J Gastroenterol 2004, 10:476-480.
33. Hu YC, Lam KY, Law S, Wong J, Srivastava G. Identification of differentially expressed genes in esophageal squamous cell carcinoma (ESCC) by cDNA expression array: overexpression of Fra-1, Neogenin, Id-1, and CDC25B genes in ESCC. Clin Cancer Res 2001, 7:2213-2221.
34. Soto U, Das BC, Lengert M, Finzer P, zur Hausen H, Rosl F. Conversion of HPV 18 positive non-tumorigenic HeLa-fibroblast hybrids to invasive growth involves loss of TNF-alpha mediated repression of viral transcription and modification of the AP-1 transcription complex. Oncogene 1999, 18:3187-3198.
35. Sinke RJ, Tanigami A, Nakamura Y, Geurts van Kessel A. Reverse mapping of the gene encoding the human fos-related antigen-1 (fra-1) within chromosome band 11q13. Genomics 1993, 18:165.
36. Shirsat NV, Shaikh SA. Overexpression of the immediate early gene fra-1 inhibits proliferation, induces apoptosis, and reduces tumourigenicity of c6 glioma cells. Exp Cell Res 2003, 291:91-100.
37. Mishra A, Bharti AC, Saluja D, Das BC. Trans-activation and expression patterns of jun and fos/AP-1 super-family proteins in human oral cancer. Int J Cancer 2009, DOI-10.1002/ijc.24807.
38. Das BC, Hussain S, Nasare V, Bharadwaj M. Prospects and prejudices of human papillomavirus vaccines in India. Vaccine 2008, 26:2669-2679.
39. de Villiers EM, Lavergne D, Chang F, Syrjanen K, Tosi P, Cintorino M, Santopietro R, Syrjanen S. An interlaboratory study to determine the presence of human papillomavirus DNA in esophageal carcinoma from China. Int J Cancer 1999, 81:225-228.
40. Fakhry C, Gillison ML. Clinical implications of human papillomavirus in head and neck cancers. J Clin Oncol 2006, 24:2606-2611.
41. Datta NR, Kumar P, Singh S, Gupta D, Srivastava A, Dhole TN. Does pretreatment human papillomavirus (HPV) titers predict radiation response and survival outcomes in cancer cervix?--a pilot study. Gynecol Oncol 2006, 103:100-105.